The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.

Exscientia, the UK-based artificial intelligence-powered drug discovery platform spun out of University of Dundee, went public on Friday after raising more than $304m in its initial public offering on the Nasdaq Global Select Market. The spinout issued more than 13.8 million American Depositary Shares (ADSs) – representing the same number of ordinary shares – priced at…

The rest of this content is only accessible to Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.